Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950103-17-001350
Filing Date
2017-02-13
Accepted
2017-02-13 16:04:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SC 13G dp72902_sc13g-varuma.htm SC 13G 30009
  Complete submission text file 0000950103-17-001350.txt   31454
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89853 | Film No.: 17599002
SIC: 2834 Pharmaceutical Preparations

Mailing Address AESCHENVORSTADT 55 CH-4051 BASEL V8 00000
Business Address AESCHENVORSTADT 55 CH-4051 BASEL V8 00000 41 61 205 18 20
Varuma AG (Filed by) CIK: 0001697210 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G